Journal of Antimicrobial Chemotherapy (1996) 37, 473-481
© 1996 The British Society for Antimicrobial Chemotherapy
research-article |
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro
aDepartment of Clinical Microbiology, CPL, St. James's Hospital Dublin 8, Ireland bDepartment of Gastroenterology, Meath/Adelaide Hospitals Trinity College, Dublin, Ireland
Received 7 June 1995; returned 25 August 1995; accepted 27 October 1995
*Current and corresponding address: Dr H.-X. Xia, Clinical Sciences Building, Nepean Hospital. P.O. Box 63, Penrith. NSW 2751, Australia. Tel: +61-47-242682; Fax: +61-47-242614: E-mail Xia(a blackburn.med.su.oz.au.
Susceptibilities to clarithromycin and metronidazole of 444 Helicobacter pylori isolates cultured from antral biopsies of 444 dyspeptic patients were determined by disc diffusion tests (15 µg disc for clarithromycin, 5 µg disc for metronidazole). Susceptibility of 46 of these isolates to erythromycin (5 µg disc) was also tested. Minimal inhibitory concentrations (MICs) of clarithromycin for 42 selected isolates were determined by a plate dilution method. A zone diameter of 30 mm was defined as a ‘cut-off’ size differentiating susceptibility and resistance of the organism to clarithromycin, by comparing results obtained with the two methods. Of the 444 isolates, 424 (95.5%) were highly sensitive to clarithromycin, with zone diameters ranging from 30 to 98 mm. Twenty isolates (4.5%) were defined as resistant to clarithromycin, with zone diameters ranging between 6 and 28 mm. The incidence of clarithromycin resistance was similar in men and women and in different age groups, and was not significantly different between patients with peptic ulcer and non-ulcer dyspepsia. Among the 444 isolates, 168 (37.8%) were metronidazole resistant. There was cross resistance between clarithromycin and erythromycin, but not between clarithromycin and metronidazole. Stability of clarithromycin resistance was evaluated by the disc diffusion test and confirmed by the plate dilution method. Among the 20 clarithromycin-resistant isolates, nine (45%) reverted to be sensitive after 2–5 subcultures on drug-free agar. The findings in this study indicate that the incidence of clarithromycin-resistant H. pylori m untreated dyspeptic patients is low. Cross-resistance occurs between macrolides and resistance to clarithromycin in some strains is reversible.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-C. Wang, W.-Y. Li, D.-C. Wu, J.-J. Wang, C.-H. Wu, J.-J. Liao, and C.-K. Lin In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3{beta}-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori Evid. Based Complement. Altern. Med., September 22, 2009; (2009) nep147v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-A. Moder, F. Layer, W. Konig, and B. Konig Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing J. Med. Microbiol., October 1, 2007; 56(10): 1370 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gibreel, V. N. Kos, M. Keelan, C. A. Trieber, S. Levesque, S. Michaud, and D. E. Taylor Macrolide Resistance in Campylobacter jejuni and Campylobacter coli: Molecular Mechanism and Stability of the Resistance Phenotype Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2753 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Megraud H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut, September 1, 2004; 53(9): 1374 - 1384. [Full Text] [PDF]
|
|
|
|
|
|
B. Vester and S. Douthwaite Macrolide Resistance Conferred by Base Substitutions in 23S rRNA Antimicrob. Agents Chemother., January 1, 2001; 45(1): 1 - 12. [Full Text]
|
|
|
|
 |
|
 T. Alarcon, D. Domingo, N. Prieto, and M. Lopez-Brea Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA J. Antimicrob. Chemother., October 1, 2000; 46(4): 613 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Debets-Ossenkopp, A. B. Brinkman, E. J. Kuipers, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters Explaining the Bias in the 23S rRNA Gene Mutations Associated with Clarithromycin Resistance in Clinical Isolates of Helicobacter pylori Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2749 - 2751. [Abstract] [Full Text]
|
|
|
|
|
|
M. Sörberg, H. Hanberger, M. Nilsson, A. Björkman, and L. E. Nilsson Risk of Development of In Vitro Resistance to Amoxicillin, Clarithromycin, and Metronidazole in Helicobacter pylori Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1222 - 1228. [Abstract] [Full Text]
|
|